MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.250
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $76 million as of July 31, 2026. Its market cap has increased by 55.76% in one year.
Market Cap
76.00M
Enterprise Value
41.59M
1-Year Change
55.76%
Ranking
Category
Stock Price
$1.25
ChartMarket Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $76.00M, an increase of 48.73%. That is a compound annual growth rate of 10.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 76.00M | 29.81% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 83.21M |
| Gossamer Bio | 82.86M |
| PolyPid | 82.26M |
| Cognition Therapeutics | 79.62M |
| NeurAxis | 77.40M |
| Atara Biotherapeutics | 75.51M |
| Champions Oncology | 74.47M |
| Annovis Bio | 74.45M |